With patent-expiring, cash-rich, big-pharmas on a lookout for juicy candidates like ALKS these days, this $28++ target speculated here is indeed achievable in short order. Billionaires want to mostly bet on sure things; this is now as close to it as one can get!
IMHO (Please do your thorough due-diligence): A possible scenario with which this can materialize now is as follows: Oct 11 - $17.50 Oct 12 - $20.00 Oct 13 - $21.50 (after street upgrades, target-raises etc., conservatively)
Nov: Some big-pharma big-shot finally sees the light (and the pipeline / generic-techniques' potential), and makes a bid for the company for an enterprise-value north of 3B ... bingo... you have bettered your target by $2 and reached $30++!
You are also long in years and getting senile. Put your teeth back in a get yourself some fiber.
DD does not include forecasting price targets without revenue and earnings expectations for a scientific determination of a future price or using a dividend discount model which in this case would be worthless. Comparison to similiarly cap sized competitors maybe??
But pre-electiobn market momentum and WTF is devaluation momentum? Are you talking about our currency?
Dear lord, you need an education on security analysis and valuation metrics. I would not suggest a CFA or anything, but a good vanguard index fund would do you a lot better.
Thanks for revealing here that you are a short afterall privatew*! This is good news for longs then, because there is much more firepower still left for the rally to continue here! Rally will continue for some time; it will be your choice as to when to finally cover- 17, 20, 23, Or- ...!